Stem Cell-Based Regenerative Medicine in Canine Practice (eBook)
962 Seiten
Wiley (Verlag)
978-1-394-25326-5 (ISBN)
A practical guide to stem cell-based regenerative techniques in dogs
Stem Cell-Based Regenerative Medicine in Canine Practice delivers an essential reference for the use of stem cells in canine practice. Intuitively organized by organ and body systems, the book is easy-to-follow, and addresses many common conditions encountered when dealing with dogs in veterinary practice, including those affecting the central nervous system, muscular system, and vascular system.
The book is grounded in evidence-based research and readers are provided with guidance on the potential challenges and problems that may arise when considering and using stem cell therapeutics. It also explains the techniques for stem cell extraction and how to use stem cell regenerative medicine for the best results.
Readers will also find:
- An introduction to the treatment of various clinical conditions like corneal ulcers and keratoconjunctivitis
- Comprehensive explorations of the treatment of osteoarthritis, bone gap defects, tendon/ligament injuries, muscle affections, peripheral nerves, periodontitis, esophageal ulcers, inflammatory bowel disease, liver, diabetes, and skin wounds
- Practical discussions of canine mesenchymal stem cell sources, properties, and regulations for clinical use
- An overview of comparative analysis between various stem cells for therapeutics
- Complimentary access to a website containing reference videos and clinical guidance
Written for veterinarians in general practice, Stem Cell-Based Regenerative Medicine in Canine Practice will also benefit veterinary students and researchers.
The Author
Mudasir Bashir Gugjoo, PhD, is a Senior Assistant Professor at the Division of Veterinary Clinical Complex, Faculty of Veterinary Sciences & Animal Husbandry of the Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir, India.
A practical guide to stem cell-based regenerative techniques in dogs Stem Cell-Based Regenerative Medicine in Canine Practice delivers an essential reference for the use of stem cells in canine practice. Intuitively organized by organ and body systems, the book is easy-to-follow, and addresses many common conditions encountered when dealing with dogs in veterinary practice, including those affecting the central nervous system, muscular system, and vascular system. The book is grounded in evidence-based research and readers are provided with guidance on the potential challenges and problems that may arise when considering and using stem cell therapeutics. It also explains the techniques for stem cell extraction and how to use stem cell regenerative medicine for the best results. Readers will also find: An introduction to the treatment of various clinical conditions like corneal ulcers and keratoconjunctivitisComprehensive explorations of the treatment of osteoarthritis, bone gap defects, tendon/ligament injuries, muscle affections, peripheral nerves, periodontitis, esophageal ulcers, inflammatory bowel disease, liver, diabetes, and skin woundsPractical discussions of canine mesenchymal stem cell sources, properties, and regulations for clinical useAn overview of comparative analysis between various stem cells for therapeuticsComplimentary access to a website containing reference videos and clinical guidance Written for veterinarians in general practice, Stem Cell-Based Regenerative Medicine in Canine Practice will also benefit veterinary students and researchers.
Abbreviations
- 18F‐FDG:
- F‐fluorodeoxyglucose
- 2D:
- 2‐Dimensional
- 3‐D:
- 3 dimensional
- 4HNE:
- 4‐Hydroxynenonal
- 5‐Aza:
- 5‐Aza‐2′‐deoxycytidine
- 5‐HT:
- Serotonin
- 99mTc‐MIBI:
- 99mTc‐sestamibi
- 99mTcO4−:
- 99mTc‐pertechnetate
- ABCG2:
- ATP‐binding cassette (ABC) transporters
- AC:
- Adenylate cyclase
- ACI:
- Autologous chondrocyte implantation
- ACM:
- Acellular matrix
- ACTA2:
- Actin alpha 2
- AD:
- Adipose tissue
- ADAMTS:
- Disintegrin and metalloproteinase thrombospondin‐like motifs
- ADAMTS16:
- ADAM metallopeptidase with thrombospondin type 1 motif 16
- AF:
- Anal furunculosis
- AFP:
- Alpha‐fetoprotein
- AKI:
- Acute kidney injury
- AKT:
- Ak strain transforming
- ALB:
- Albumin
- ALDH1A3:
- Aldehyde dehydrogenase 1A3
- ALI:
- Acute lung injury
- ALK5:
- Activin receptor‐like kinase 5
- ALP:
- Alkaline phosphatase
- ALT:
- Alanine transaminase
- AM:
- Amniotic membrane
- AMPs:
- Antimicrobial peptides
- ANG:
- Angiopoietin
- Anpep:
- Aminopeptidase N
- AP:
- Apical ligament
- AQP1:
- Aquaporin 1
- ARDS:
- Acute respiratory distress syndrome
- ARE:
- Antibiotic responsive enteropathy
- AST:
- Aspartate aminotransferase
- AT3:
- Antithrombin 3
- ATF6:
- Activating transcription factor 6
- ATMPs:
- Advanced therapy medicinal products
- ATP:
- Adenosine triphosphate
- ATR:
- Angiotensin receptor
- AURKA:
- Aurora‐A kinase
- AV:
- Atrioventricular
- Bad:
- Bcl‐2–associated death protein
- Bax:
- Bcl‐2–associated X protein
- BBB:
- Blood–brain barrier
- BCL‐2:
- B‐cell lymphoma 2
- BCP:
- Biphasic calcium phosphate
- BC‐TS:
- Tubular bacterial cellulose
- BDKRB2:
- Bradykinin receptor B2
- BDNF:
- Brain‐derived nerve factor
- BDNF:
- Brain‐derived neurotrophic factor
- bFGF:
- Basic fibroblast growth factor
- BglII:
- Bacillus globigii‐derived type II restriction endonuclease
- BHA:
- Butylated hydroxyanisole
- BIC:
- Bone implant contact
- BM‐:
- Bone marrow
- BMA:
- Bone marrow aspirate
- BMD:
- Bone mineral density
- BME:
- β‐Mercaptoethanol
- BMP:
- Bone morphogenetic factor
- BrdU:
- Bromodeoxyuridine
- BST1:
- Bone marrow stromal cell antigen‐1
- BTE:
- Bone tissue engineering
- BUN:
- Blood urea nitrogen
- C/ABB:
- Chitosan/anorganic bovine bone
- CADESI‐4:
- Canine atopic dermatitis extent severity index‐4
- CAGR:
- Compound annual growth rate
- cAMP:
- 3′5‐cyclic monophosphate monohydrate
- CARD15:
- Caspase recruitment domain‐containing protein 15
- CBC:
- Complete blood count
- CBPI:
- Canine Brief Pain Inventory
- CCAAT/EBPα:
- Cytosine–cytosine–adenosine–adenosine–thymidine enhancer binding protein
- CCECAI:
- Canine Chronic Enteropathy Clinical Activity Index
- CCL2:
- C‐C motif ligand 2
- CCl4:
- Carbon tetrachloride
- CCNB1:
- Cyclin B1
- CD:
- Canine distemper
- CD:
- Cluster of differentiation
- CDCs:
- Cardiosphere‐derived stem cells
- CdHA:
- Calcium‐deficient hydroxyapatite
- CDK1:
- Cyclin‐dependent kinase 1
- Cdkn1a:
- Cyclin‐dependent kinase inhibitor 1A
- CDV:
- Canine distemper virus
- CDX4:
- Caudal Type Homeobox 4
- CFU(f):
- Colony forming unit(fibroblasts)
- CGRP:
- Calcitonin gene‐related peptide
- CHF:
- Congestive heart failure
- CHOP:
- C/EBP Homologous Protein
- CIBDAI:
- Clinical Inflammatory Bowel Disease Activity Index
- CIE:
- Chronic inflammatory enteropathy
- CIMVs:
- Cytochalasin B‐induced membrane vesicles
- C‐jun:
- Jun Proto‐Oncogene
- CK19:
- Cytokeratin19
- CKD:
- Chronic kidney disease
- CLEC3A:
- C‐type lectin domain family 3 member A
- CM:
- Conditioned medium
- CMAP:
- Compound muscle action potential
- CMC:
- Carboxy methyl cellulose
- CMR:
- Cardiovascular magnetic resonance
- c‐MYC:
- Cellular myelocytomatosis
- CNS:
- Central nervous system
- CNTF:
- Ciliary neurotrophic factor
- COL2A:
- Collagen 2A
- COL3A1:
- Collagen 3A1
- Coll I:
- Collagen I
- COX:
- Cyclooxygenase
- CPB:
- Cardiopulmonary bypass
- CPS:
- Calcium phosphate scaffold
- CrCL:
- Cranial cruciate ligament
- CRI:
- Continuous rate infusion
- CRISPR:
- Clustered regularly interspaced short palindromic repeats
- CRP:
- C‐reactive protein
- CSA:
- Cyclosporin A
- CSF:
- Cerebrospinal fluid
- CSG:
- Chondroitin sulphate glycosaminoglycan
- CSH:
- Calcium sulfate hemihydrate
- CTGF:
- Connective tissue growth factor
- CTI:
- Cardiac troponin I
- CTNND2:
- Catenin delta 2
- CTT:
- Cardiac troponin T
- CVM:
- Centre for veterinary medicine
- Cx45:
- Connexin 45
- CXCR4:
- C‐X‐C chemokine receptor type 4
- CYP:
- Cytochrome P450
- DAPT:
- N‐[N‐(3,5‐Difluorophenacetyl)‐L‐alanyl]‐S‐phenylglycine t‐butyl ester
- dbCAMP:
- Dibutyryl Cyclic Adenosine Monophosphate
- DCM:
- Dilatation cardiomyopathy
- DCN:
- Decorin
- DCs:
- Dendritic cells
- DDFT:
- Deep digital flexor tendon
- DE:
- Definitive endoderm
- DED:
- Dry eye disease
- Dexa:
- Dexamethasone
- DFE:
- Dermatophagoides farinae extract
- DISA:
- Dual isotope simultaneous acquisition
- DKA:
- Diabetic ketoacidosis
- DKK1:
- Dickkopf‐1
- DLA:
- Dog leukocyte antigen
- DM:
- Diabetes mellitus
- DMD:
- Duchenne’s muscle dystrophy
- DMEM:
- Dulbecco’s minimally essential medium
- DMEM‐HG:
- Dulbecco’s modified Eagle’s Media‐High Glucose
- dMSCs:
- Dog mesenchymal stem cells
- DMSO:
- Dimethyl sulfoxide
- dMyHC:
- Developmental myosin heavy chain
- DNA:
- Deoxyribonucleic acid
- DP:
- Dental pulp
- DRB1:
- Major Histocompatibility Complex, Class II, DR Beta 1
- DTEF:
- Divergent transcriptional enhancer factor
- ECG:
- Electrocardiography
- ECM:
- Extracellular matrix
- ECMO:
- Extracorporeal membrane oxygenation
- EDNRA:
- Endothelin receptors
- EDVI:
- End diastolic volume index
- EF:
- Ejection fraction
- EGF:
- Epidermal growth factor
- EGFP:
- Enhanced green fluorescent protein
- Egr1:
- Early response protein
- ELISA:
- Enzyme‐linked immunosorbent assay
- EMT:
- Epithelial–mesenchymal transition
- eNOS:
- Endothelial nitric oxide synthase
- Eomes:
- Eomesodermin
- Epac2:
- Exchange Protein Directly Activated by cAMP 2
- EPCS:
- Electric‐pulse current stimulation
- EPCs:
- Endothelial progenitor cells
- EPO:
- Erythropoietin
- EPOR:
- Erythropoietin receptor
- ER:
- Endoplasmic reticulum
- ERK:
- Extracellular signal‐regulated kinase
- ESCs:
- Embryonic stem cells
- ESD:
- Endoscopic submucosal dissection
- ESF:
- External skeletal fixation
- ESVI:
- End systolic volume index
- EVs:
- Extracellular vesicles
- FBS:
- Fetal bovine serum
- FDA:
- Food and Drug Administration
- FDMBB:
- Freeze‐dried mineral bone block
- FGF:
- Fibroblast growth factor
- FGFR:
- Fibroblast growth factor receptor 2
- FGFR1:
- Fibroblast growth factor 1 receptor
- FISH:
- Fluorescence in situ hybridization
- Foxa1:
- Forkhead box protein A genes
- ...
| Erscheint lt. Verlag | 28.5.2025 |
|---|---|
| Sprache | englisch |
| Themenwelt | Veterinärmedizin |
| Schlagworte | canine regenerative medicine • canine regenerative veterinary medicine • canine stem cell properties • canine stem cell regulations • Canine stem cells • canine stem cell sources • canine stem cell treatment • canine stem cell videos • veterinary stem cell |
| ISBN-10 | 1-394-25326-5 / 1394253265 |
| ISBN-13 | 978-1-394-25326-5 / 9781394253265 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich